The impact of training image quality with a novel protocol on artificial intelligence-based LGE-MRI image segmentation for potential atrial fibrillation management.

Journal: Computer methods and programs in biomedicine
PMID:

Abstract

BACKGROUND: Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting up to 2 % of the population. Catheter ablation is a promising treatment for AF, particularly for paroxysmal AF patients, but it often has high recurrence rates. Developing in silico models of patients' atria during the ablation procedure using cardiac MRI data may help reduce these rates.

Authors

  • A K Berezhnoy
    Laboratory of Experimental and Cellular Medicine, Moscow Institute of Physics and Technology, Dolgoprudny, 141701, Russia; M. F. Vladimirsky Moscow Regional Research Clinical Institute, Moscow, 129110, Russia; ITMO University, Kronverksky Pr. 49, bldg. A, St. Petersburg, 197101, Russia. Electronic address: info@phystech.edu.
  • A S Kalinin
    Laboratory of Experimental and Cellular Medicine, Moscow Institute of Physics and Technology, Dolgoprudny, 141701, Russia.
  • D A Parshin
    ITMO University, Kronverksky Pr. 49, bldg. A, St. Petersburg, 197101, Russia.
  • A S Selivanov
    Laboratory of Experimental and Cellular Medicine, Moscow Institute of Physics and Technology, Dolgoprudny, 141701, Russia.
  • A G Demin
    ITMO University, Kronverksky Pr. 49, bldg. A, St. Petersburg, 197101, Russia.
  • A G Zubov
    ITMO University, Kronverksky Pr. 49, bldg. A, St. Petersburg, 197101, Russia.
  • R S Shaidullina
    ITMO University, Kronverksky Pr. 49, bldg. A, St. Petersburg, 197101, Russia.
  • A A Aitova
    Laboratory of Experimental and Cellular Medicine, Moscow Institute of Physics and Technology, Dolgoprudny, 141701, Russia; M. F. Vladimirsky Moscow Regional Research Clinical Institute, Moscow, 129110, Russia; ITMO University, Kronverksky Pr. 49, bldg. A, St. Petersburg, 197101, Russia.
  • M M Slotvitsky
    Laboratory of Experimental and Cellular Medicine, Moscow Institute of Physics and Technology, Dolgoprudny, 141701, Russia; M. F. Vladimirsky Moscow Regional Research Clinical Institute, Moscow, 129110, Russia; ITMO University, Kronverksky Pr. 49, bldg. A, St. Petersburg, 197101, Russia.
  • A A Kalemberg
    M. F. Vladimirsky Moscow Regional Research Clinical Institute, Moscow, 129110, Russia.
  • V S Kirillova
    Federal State Budgetary Institution "National Medical Research Center named after Academician E.N. Meshalkin" of the Ministry of Health of the Russian Federation, Novosibirsk, 630007, Russia.
  • V A Syrovnev
    Federal State Budgetary Institution "Clinical Hospital No. 1" of the Office of the President of the Russian Federation, Moscow, 121352, Russia.
  • K I Agladze
    Laboratory of Experimental and Cellular Medicine, Moscow Institute of Physics and Technology, Dolgoprudny, 141701, Russia; M. F. Vladimirsky Moscow Regional Research Clinical Institute, Moscow, 129110, Russia.
  • V A Tsvelaya
    Laboratory of Experimental and Cellular Medicine, Moscow Institute of Physics and Technology, Dolgoprudny, 141701, Russia; M. F. Vladimirsky Moscow Regional Research Clinical Institute, Moscow, 129110, Russia; ITMO University, Kronverksky Pr. 49, bldg. A, St. Petersburg, 197101, Russia. Electronic address: tsvelaya@phystech.edu.